(Q53318292)

13 May 2018

title

Reduction of [(18)F]fluoromisonidazole uptake after neoadjuvant chemotherapy for head and neck squamous cell carcinoma. (English)

1 reference

13 May 2018

author

Tomohiko Yamane

1

1 reference

13 May 2018

Shogo Shinohara

3

1 reference

13 May 2018

author name string

Masahiro Kikuchi

2

1 reference

13 May 2018

Michio Senda

4

1 reference

13 May 2018

publication date

1 April 2011

1 reference

13 May 2018

Molecular Imaging and Biology

published in

1 reference

13 May 2018

volume

13

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

227-231

1 reference

13 May 2018

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0365-2

The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0365-2

Hypoxia dose painting by numbers: a planning study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0365-2

Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0365-2

Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0365-2

Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0365-2

Fully automated one-pot synthesis of [18F]fluoromisonidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0365-2

Fully automated synthesis of [18F]fluoromisonidazole using a conventional [18F]FDG module

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0365-2

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0365-2

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation O

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0365-2

Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0365-2

Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0365-2

A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0365-2

pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the pu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0365-2

Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0365-2

Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

21 January 2018

1 reference

12 December 2020

Comparison of the distribution of fluorine-18 fluoromisonidazole, deoxyglucose and methionine in tumour tissue

1 reference

12 December 2020

Phase I study of S-1 and nedaplatin for patients with recurrence of head and neck cancer

1 reference

12 December 2020

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.

1 reference

12 December 2020

10.1007/S11307-010-0365-2

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018